According to stock market observers, shares of the company are available at a premium of ₹242 in the grey market today

The basis of allotment for Senores Pharmaceuticals IPO shares is set to be finalised on Thursday, December 26, 2024. Investors who subscribed to the public offering can check their allotment status on the official websites of BSE,

The IPO comprises a fresh issue of shares worth Rs 500 crore and an offer-for-sale (OFS) of up to 21,00,000 equity shares by promoters and existing shareholders.

Bidding for the initial public offering (IPO) of Senores Pharmaceuticals Limited began on 20 December 2024 and will remain open until 24 December 2024. So, investors have just one day to apply for the Senores Pharmaceuticals IPO as bidding for the public issue ends today at 5:00 PM.

Senores Pharmaceuticals IPO receives robust response, priced at ₹372-391, with proceeds for subsidiary investment, manufacturing, and working capital.

Analysts have recommended investors subscribe to the issue, citing attractive valuations and strong demand for pharmaceuticals. At the upper price band, the company is valued at a P/E ratio of 55x, with a market capitalization of Rs 1,

Senores Pharmaceuticals' initial public offering garnered 13.88 times subscription on Monday, the day two of bidding.

A mid the ongoing flurry of IPOs, three issues- Ventive Hospitality, Senores Pharmaceuticals and Carraro India- which opened for bidding on Friday, December 20, are eyeing to cumu